Medicine and Health

Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCESO1 trial

J. Qin, L. Xue, et al.

This groundbreaking phase 3 trial evaluates the combination of neoadjuvant camrelizumab with chemotherapy against chemotherapy alone in patients with locally advanced esophageal squamous cell carcinoma. Notably, it demonstrates superior pathological complete response rates, paving the way for innovative treatment options. The research was conducted by an extensive team of experts from leading institutions.

00:00

~3 min • Beginner • English

Related Publications

Explore these studies to deepen your understanding of the subject.

Medicine and Health

Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial

M. Schuler, K. Cuppens, et al.

Medicine and Health

Neoadjuvant pembrolizumab, dabrafenib and trametinib in BRAFV600-mutant resectable melanoma: the randomized phase 2 Neo Trio trial

G. V. Long, M. S. Carlino, et al.

Medicine and Health

The effects of omega 3 fatty acids on the serum concentrations of pro inflammatory cytokines and depression status in patients with bipolar disorder: A randomized double-blind controlled clinical trial

H. Eslahi, M. Shakiba, et al.

Medicine and Health

Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses

R. J. Kelly, B. V. Landon, et al.

Listen, Learn & Level Up

Over 10,000 hours of research content in 25+ fields, available in 12+ languages.

No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.

listen to research audio papers with researchbunny